OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

OncoDaily
Apr 12, 2024, 12:10 | Insight
Piotr Wysocki: Cetuximab monotherapy maintenance after FOLFIRI may not be the optimal choice but can be considered in selected mCRC patients
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 12, 2024, 11:59 | Insight
Wei Zhang: Congratulations to an outstanding physician scientist Tim Pardee for the new R21 grant that addresses health disparities in acute myeloid leukemia
Wei Zhang, Director at Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer…
Apr 12, 2024, 11:49 | Drugs
Vasileios Askoxylakis: Promising clinical data from the Phase 1 study of the CCR7 targeting antibody-drug conjugate JBH492
Vasileios Askoxylakis, Vice President, Global Head Oncology Early Clinical Development at Servier, shared on LinkedIn: "Very…
Apr 12, 2024, 11:46 | Drugs
Piotr Wysocki: Adjuvant treatment with Alectinib in resected ALK-positive non-small cell lung cancer – interim analysis results of ALINA trial published in NEJM
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University Hospital,…
Apr 12, 2024, 11:39 | Insight
Maite Gorostegui: Our Childhood Cancer Survivors Unit has a beautiful Catalan Name: SEGUIM
Maite Gorostegui, Chair of the SIOP Global Mapping Programme, shared on LinkedIn: "Our Childhood Cancer…
Apr 12, 2024, 11:39 | Blog
Faster, farther, together - St. Jude Children's Research Hospital
St. Jude Children's Research Hospital posted on LinkedIn: "Faster, farther, together. By fostering a collaborative working…
Apr 12, 2024, 11:31 | Blog
Scott Gottlieb: I had the opportunity to discuss the accelerated approval of cancer drugs on CNBC and share insights from a recent JAMA study
Scott Gottlieb, Partner at New Enterprise Associates, shared on LinkedIn: "Today, I had the opportunity to…
Apr 12, 2024, 11:30 | Career
Dr. Louise Guolla elected Vice-Chair of the Young SIOP Network
International Society of Pediatric Oncology posted on LinkedIn: "Congratulations to Dr. Louise Guolla (Canada) on being…
Apr 12, 2024, 11:25 | Insight
A Paper in Nature Genetics identifies 41 cell subtypes and highlights age and parity-dependent effects in analysis of over 800.000 human adult breast cells - Nature Portfolio
Apr 12, 2024, 11:15 | Insight
Robert Miller: How many adult patients with cancer participate in clinical trials?
Robert Miller, Chief Medical Science Officer at CancerLinQ, shared on LinkedIn: "How many adult patients…
Apr 12, 2024, 11:09 | Blog
George Yaghmour: Excited to share our recent findings on FLT3 inhibitor maintenance therapy post-HSCT
George Yaghmour, Associate Director of USC Norris Blood and Marrow Transplant Program at University of Southern…
Apr 12, 2024, 11:02 | Blog
Nicholas Navin: Systems Biology at the MD Anderson Cancer Center in Houston, Texas is recruiting faculty
Nicholas Navin, Professor and Chair, Department of Systems Biology at MD Anderson Cancer Center, shared on…
Apr 12, 2024, 10:55 | Drugs
Sami Mansfield: How Common Medications Impact Exercise
Sami Mansfield, Founder of Cancer Wellness for Life, shared on LinkedIn: "Hello, fellow health and fitness…
Apr 12, 2024, 10:44 | Societies
Simul Parikh: Getting excited about benign radiotherapy!
Simul Parikh, Medical Director of OncoHealth, recently posted on LinkedIn: "It is an absolute delight…
Apr 12, 2024, 10:23 | Blog
International Society of Paediatric Oncology 2023 Annual Report
International Society of Paediatric Oncology - SIOP shared on LinkedIn: "Have you read our 2023…
Apr 12, 2024, 10:14 | Societies
Shiva Bolourchi: Marengo Therapeutics is proud to be disclosing new data at AACR describing the innovative expansion of our portfolio
Ke Liu, Chief Development Officer at Marengo Therapeutics, shared a post by Shiva Bolourchi, Head…
Apr 12, 2024, 10:05 | Drugs
Piotr J. Wysocki: Immunotherapy combined with tyrosine-kinase inhibitor is not better than docetaxel in NSCLS patients after first-line chemoimmunotherapy failure
Piotr J. Wysocki, Head of the Oncology Department at the University Hospital Krakow, shared a post…
Apr 12, 2024, 09:45 | Blog
Estela Rodriguez: Proud to work with LUNGevity Foundation and team to develop a discussion guide for biomarker testing for patients with solid tumors in plain language
Estela Rodriguez shared on X/Twitter: "Proud to work with LUNGevity Foundation and team to develop a discussion…
Apr 12, 2024, 09:38 | Societies
Medical institutions in LMICs in Central and Eastern Europe region are invited to participate in ASCO education and knowledge-exchange program
ASCO shared a post on X: "Medical institutions in Lower Middle income countries in Central and…
Apr 12, 2024, 09:26 | Insight
In this Letter to the Editor, the Cancer Immunotherapy AEs Working Group details the pitfalls of reporting in immunotherapy clinical trials - Annals of Oncology
Annals of Oncology shared a post on X: "Immune checkpoint inhibitors are now standard-of -care in…
Apr 12, 2024, 09:11 | Opinion
Piotr J. Wysocki: PSA screening does reduce prostate cancer mortality, but the overall benefit is small, according to a secondary analysis of the CAP trial
Piotr J. Wysocki, Head of Department of Oncology at Jagiellonian University Hospital, shared a post…
Apr 12, 2024, 08:54 | Insight
Daphne Zohar: Giving life to science
Daphne Zohar, Founder and CEO of Seaport Therapeutics, shared a post on LinkedIn: "We have some…
Apr 12, 2024, 08:22 | Insight
Eduardo Pisani: Another major milestone this week for 4PCAN Project on cancer primary prevention
Eduardo Pisani, CEO of All.Can, shared a post on LinkedIn: “Another major milestone this week for 4PCAN…
Apr 12, 2024, 08:11 | Blog
Angela Mastronuzzi: The necessity to adopt the new classification when considering therapeutic options
Angela Mastronuzzi shared a post on LinkedIn: "Our recently published paper is out with Frontiers!…
Apr 12, 2024, 08:00 | Blog
IARC and Halle University signed an MoU on cooperation in cancer research
IARC shared a post on X: "IARC and Halle University signed an MoU (memorandum of understanding)…
Apr 12, 2024, 07:30 | Blog
Urvi Shah: Grateful that our paper was selected for the inaugural Clinical Cancer Research early career award
Urvi Shah, Hematologist-oncologist at Memorial Sloan Kettering Cancer Center, shared a post on X: "Thank…
Apr 12, 2024, 06:01 | Positive
The leaders who are actively shaping healthcare policy, biotechnology, and pharmaceutical industries in Europe - EU Insider
Dégi László Csaba, President of the European Cancer Organisation, shared a post by EU Insider…
Apr 12, 2024, 05:54 | Blog
Stefanie Corradini: A big shoutout to Sebastian N. Marschner for pioneering our first “Shark Tank” style audition where residents got the chance to pitch their scientific projects
Apr 12, 2024, 05:45 | Blog
Humaid Al-Shamsi: During the Eid holiday, Burjeel Holdings to open additional clinics throughout the holiday period
Humaid Al-Shamsi, Director of the Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared a post…
Apr 12, 2024, 05:40 | Insight
Rajkumar Venkatramani: I got rejected and it was the best thing that happened to me
Rajkumar Venkatramani, Section Chief of Oncology at Texas Children’s Hospital, shared a post on LinkedIn: "I…
Apr 12, 2024, 05:34 | Insight
Joe Lennerz: Quickly sharing a fantastic paper on tumour infiltrating lymphocytes in triple-negative breast cancer
Joe Lennerz, Chief Scientific Officer at BostonGene, shared on LinkedIn: "Quickly sharing a fantastic paper…
Apr 12, 2024, 05:23 | Positive
John Tarantino: I couldn’t ask for a better leaders
John Tarantino, Chief Executive Officer at Iylon Precision Oncology, shared on LinkedIn: "From a patient…
Apr 12, 2024, 05:16 | Drugs
Tanja Obradovic: Era of antibody drug conjugates just got even more exciting with the first tumor-agnostic approval for ADC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: "Era…
Apr 12, 2024, 05:12 | Positive
Gemma Peters: Macmillan's metamorphosis
Gemma Peters, Chief Executive Officer at Macmillan Cancer Support, shared a post on LinkedIn: "On…
Apr 12, 2024, 05:04 | Career
Margaret Foti: Dr. Patricia LoRusso will become the seventh woman AACR President
Margaret Foti recently shared a post by the American Association for Cancer Research (AACR), on…
Apr 12, 2024, 03:19 | Dialogues
OncoInfluencers: Dialogue with Pasi Jänne, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In…
Apr 11, 2024, 18:01 | Insight
Sabine D. Brookman-May: Great lectures and abstracts presented at EAU24
Sabine D. Brookman-May, Professor of Urology at Munchen University, shared a post on X: "On top…
Apr 11, 2024, 17:56 | Blog
Christy Brown: Help us work towards wiping out childhood cancer!
Christy Brown, Senior District Sales Manager – Midwest at Medtronic, shared a post on LinkedIn:…
Apr 11, 2024, 17:46 | Blog
Amy Comander: Inside Team Ellie - Why these four women are running the Boston Marathon for breast cancer patients
Amy Comander, Director of Lifestyle Medicine at Massachusetts General Hospital Cancer Centre, posted on LinkedIn:…
Apr 11, 2024, 17:43 | Societies
Mark your calendars for our upcoming virtual Grand Rounds to explore the use of Precision Medicine through the TAPUR Study - ASCO
American Society of Clinical Oncology (ASCO) shared a post LinkedIn: “Mark your calendars for our…
Apr 11, 2024, 17:40 | Societies
James R. Downing: Thrilled to congratulate Ching-Hon Pui on receiving the AACR- St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research
Apr 11, 2024, 17:38 | Insight
Vivek Subbiah: Thrilled to be featured in AACR’s special issue of Cancer Discovery
Vivek Subbiah shared a post on X: “Thrilled to be featured in American Association for…
Apr 11, 2024, 17:37 | Societies
Our Editor Spotlight this week is John B. Haanen, editor for immunotherapy - ESMO Open
ESMO Open shared a post on X: “Our Editor Spotlight this week is John B.…
Apr 11, 2024, 17:35 | Insight
Pavlos Msaouel: So proud of mentee Xinmiao Yan for receiving an AACR Scholar in Training Award
Pavlos Msaouel, Medical Oncologist in the GU Department at MD Anderson Cancer Center, shared a…
Apr 11, 2024, 17:32 | Career
Barbara Marte: A great opportunity to join the editorial team of Nature Cancer
Barbara Marte, Senior Editor at Nature Publishing Group, shared a post by Nature Cancer on…
Apr 11, 2024, 17:30 | Societies
Folakemi T. Odedina: So proud to see our phenomenon Cheryl Willman named one of the Cancer Equity Leaders
Folakemi T. Odedina, Deputy Director of the Mayo Clinic Comprehensive Cancer Center Community Outreach and Engagement…
Apr 11, 2024, 17:27 | Career
Jon Lim: Big thanks Pezcoller Foundation for the AACR-Pezcoller Foundation Scholar-in-Training Award
Jon Lim, Medical Oncologist and Postdoctoral Clinical Fellow at The Francis Crick Institute, shared a…
Apr 11, 2024, 17:24 | Insight
Thor Halfdanarson: SSTR avid thyroid nodules are not rare and often seen on SSTR PET scan
Thor Halfdanarson, Vice President for the North American Neuroendocrine Tumor Society, made the following post…
Apr 11, 2024, 17:23 | Blog
Toni Choueiri: Back in business - The SOCCER ASCO game is back during ASCO24
Toni Choueiri recently shared a post on X: "Back in business: The SOCCER ASCO game…
Apr 11, 2024, 17:21 | Opinion
Bishal Gyawali: A crash course on surrogate endpoints in oncology and their use for regulatory approval
Bishal Gyawali, Associate Professor at Queen's University, shared a post on X: "A crash course…
Apr 11, 2024, 17:19 | Blog
Fumiko Ladd Chino: Pro tip to help the patients feel about what the next steps are
Fumiko Ladd Chino shared on X/Twitter: "Pro tip that bears repeating. If you are someone…
Apr 11, 2024, 17:17 | Insight
Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management
Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices…
Apr 11, 2024, 17:15 | Blog
Oyepeju Abioye: 'Precision Immuno-Oncology in NSCLC through Gender Equity Lenses', published in MDPI
Oyepeju Abioye, Oncology Clinical Research Assistant at Florez Laboratory of Dana-Farber Cancer Institute, shared on X:…
Apr 11, 2024, 17:12 | Blog
Danielle Carnival: New actions by US Environmental Protection Agency will reduce Americans’ exposure to toxic substances that can lead to cancer
Danielle Carnival, Deputy Assistant to President Biden for the Cancer Moonshot, shared on X/Twitter: "New…
Apr 11, 2024, 17:02 | Blog
Chiquita Brooks-LaSure: We are committed to Biden Cancer Moonshot goal to prevent cancer before it starts
Chiquita Brooks-LaSure, Administrator of Medicare and Medicaid Services, shared on X/Twitter: "For National Cancer Prevention and…
Apr 11, 2024, 16:59 | Blog
Amy Moore: LUNGevity Foundation is proud to partner with the American Lung Association to intercept lung cancer before it even begins
Amy Moore, VP of Global Engagement and Patient Partnerships at LUNGevity Foundation, shared a post…
Apr 11, 2024, 16:58 | Blog
Drew Moghanaki: Why programs that focus on lung health are very effective
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on…
Apr 11, 2024, 16:56 | Blog
Vivek Subbiah: Their leadership as early-phase clinical trialists is truly inspiring
Vivek Subbiah shared on X/Twitter: "What an honor to meet and extend congratulations to AACR…
Apr 11, 2024, 16:54 | Insight
Stacey Tinianov: Example of clinical workflow for AI usage shared by Maryellen Giger at AACR24
Stacey Tinianov, Vice President of Patient Advocacy and Engagement at Rabble Health, shared on X/Twitter: "Example…
Apr 11, 2024, 16:51 | Blog
Young Lung Cancer Initiative is at the forefront of advocacy of young patients - Florez Lab
Florez Lab shared on X/Twitter: "Did you know that young patients with lung cancer face…
Apr 11, 2024, 16:43 | Blog
The five winners for the 2023 Year of Open Science Recognition Challenge - Seattle Children's Hospital
Seattle Children's Hospital page shared on LinkedIn: "The White House Office of Science and Technology…
Apr 11, 2024, 16:41 | Blog
Udhayvir Grewal: Being a peer mentor is one of my favorite parts of being a fellow
Udhayvir Grewal, Hematology and Oncology Fellow at the University of Iowa Holden Comprehensive Cancer Center, shared…
Apr 11, 2024, 16:39 | Blog
Global Summit on War and Cancer 2023: Christos Tsagkaris' speech on the Horizon Europe Cancer Center
The 1st Global Summit on War and Cancer took place on 14 - 16 December…
Apr 11, 2024, 16:08 | Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 11, 2024, 15:57 | Insight
Marco Donia: Therapeutic Cancer Vaccines - update in Melanoma
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 11, 2024, 15:49 | Societies
Welcoming the Private Sector Council of The Access to Oncology Medicines (ATOM) Coalition - April, 2024
The Access to Oncology Medicines (ATOM) Coalition shared a post on X: “It was a pleasure…
Apr 11, 2024, 15:24 | Societies
Tambre Leighn: As part of the AACR Scientist to Survivor Program, we 'teach back' our mentors
Tambre Leighn, Founder of Well Beyond Ordinary, A Boutique Health Communications, Training, and Patient Engagement…
Apr 11, 2024, 15:23 | Drugs
Piotr Wysocki: Adagrasib and cetuximab in KRAS G12C-mutated colorectal cancer is a safe and active
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 11, 2024, 15:15 | Insight
Talha Badar: Efficacy of autologous and allogeneic hematopoietic cell transplantation in Acute Promyelocytic Leukemia
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter: “Efficacy of autologous and…
Apr 11, 2024, 15:12 | Insight
Erman Akkus: Prostate cancer screening: 2 studies of JAMA
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: ''Prostate cancer screening: 2…
Apr 11, 2024, 15:06 | Societies
Meet the ACCELERATE Working Group on Fostering Age Inclusive Research - SIOPE
European Society of Paediatric Oncology (SIOPE) shared a post on X: “Meet the ACCELERATE Working…
Apr 11, 2024, 15:04 | Insight
The new platform can modify the RNA of cells, boosts the cells’ ability to target tumors - Cancer Research Institute (CRI)
Quoting Cancer Research Institute (CRI) on LinkedIn: ''According to a study from Stanford University researchers,…
Apr 11, 2024, 14:59 | Blog
Olya Kudinenko: I am stepping down from the operational management of the Tabletochki CF
Olya Kudinenko, Founder of Tabletochki CF and Kids-of-Ukraine.org, shared a post on LinkedIn: “I never…
Apr 11, 2024, 14:59 | Blog
Kimryn Rathmell on the National Cancer Plan unveiled by Monica Bertagnolli
Kimryn Rathmell, Director of the National Cancer Institute, recently shared on X/Twitter: "One year ago…
Apr 11, 2024, 14:51 | Blog
Ruben Mesa: As the first proton beam therapy center for the Carolinas the impact will be profound for the patients across the Piedmont and beyond
Ruben Mesa, President of Atrium Health Levine Cancer, shared on LinkedIn: “Delighted by the visit…
Apr 11, 2024, 14:50 | Societies
Medicaid Cancer Foundation was privileged to be part of an impactful high-level stakeholders engagement hosted by the Honorary Minister of Health
Medicaid Cancer Foundation (MCF) shared on LinkedIn: “Medicaid Cancer Foundation (MCF) was privileged to be…
Apr 11, 2024, 14:45 | Insight
Wafik El-Deiry: Susan Galbraith speaks about AstraZeneca oncology portfolio and collaboration opportunities at the AACR Oncology Industry Partnering Event in San Diego
Wafik El-Deiry, Director of the Legorreta Cancer Center at Brown University, recently posted on LinkedIn:…
Apr 11, 2024, 14:41 | Drugs
Neil Grubert: Dramatic differences in access to Advanced Therapy Medicinal Products (ATMP) across Europe
Neil Grubert, Independent Global Market Access Consultant, shared on LinkedIn: “Dramatic differences in access to…
Apr 11, 2024, 14:40 | Insight
Simone Cesaro: The graft versus neuroblastoma effect
Simone Cesaro, Director Pediatric Hematology Oncology Unit at Integrated University Hospital of Verona, posted on…
Apr 11, 2024, 14:34 | Blog
Semiramida Markosyan: If you have ever been curious about genetics or wanted to learn how to read the human genome, this is the perfect read for you!
Semiramida Markosyan, HBSc in Genetics from the University of Toronto, posted on LinkedIn: "Just came…
Apr 11, 2024, 14:32 | Societies
Samantha Tamburro: This year's Nursing Program was such an impactful experience for my first time in-person at the NCCN Annual Conference
Samantha Tamburro, Pediatric Oncology Nurse and Chemotherapy Template Developer at the National Comprehensive Cancer Network,…
Apr 11, 2024, 14:28 | Insight
New Paper Alert! Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors
Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors  Authors: Matthew T Campbell,…
Apr 11, 2024, 14:12 | Positive
Allison Rosen: It’s not every day that I get to connect with Peter WT Pisters and say thank you
Allison Rosen, Director of Project ECHO at American Cancer Society, shared on X/Twitter: "It’s not every…
Apr 11, 2024, 14:03 | Blog
Lucile Adams-Campbell presents the AACR Distinguished Public Service Award posthumously to Worta McCaskill-Stevens - AACR
Kimryn Rathmell, NCI Director, shared a post by AACR on X/Twitter: "Today we celebrated Dr. Worta McCaskill-Stevens…
Apr 11, 2024, 13:56 | Blog
Ashwin Kishtagari: A case with distinct bone marrow findings associated with a noncanonical UBA1 variant
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X/Twitter: "We report a…
Apr 11, 2024, 13:50 | Insight
New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "50% patients develop side effects from immunotx. New blood test predicts…
Apr 11, 2024, 13:38 | Blog
Paolo Tarantino: Wonderful and fun discussions on ADCs at AACR24 with Helena Yu and Petros Grivas
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared a…
Apr 11, 2024, 13:31 | Blog
Cristiane D Bergerot: Join us in our survey on adherence to ASCO guidelines for integrating Palliative Care into standard practice
Cristiane D Bergerot shared a post on X/Twitter: "Join us in our survey on adherence to…
Apr 11, 2024, 13:23 | Blog
Isabella Faria: I reached a milestone in my early career as a surgeon-scientist -- my first 100 citations!
Isabella Faria, General surgery resident at The University of Texas Medical Branch, shared on X/Twitter: "Today,…
Apr 11, 2024, 13:16 | Career
Kristin E. Rojas: Proud to add my name to the 5% of Associate Professors in Academic Surgery who are Latinas
Kristin E. Rojas, Breast Cancer Surgeon and Women's Health Expert at NCI-Designated Sylvester Comprehensive Cancer…
Apr 11, 2024, 13:10 | Insight
Talha Badar: Differentiation syndrome with targeted therapies for myeloid malignancies
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter: "Weekend review 1/6 Differentiation syndrome…
Apr 11, 2024, 13:03 | Opinion
Bishal Gyawali: Challenges faced by oncologists in training in LMIC
Bishal Gyawali, Assistant Professor at University at Albany School of Public Health, shared on X/Twitter: "Challenges…
Apr 11, 2024, 12:58 | Blog,Drugs
Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival - JAMA Oncology
JAMA Oncology shared on X/Twitter: "Most cancer drugs granted accelerated approval did not demonstrate benefit in…
Apr 11, 2024, 12:52 | Societies
Engineering T Cells to Eradicate Tumors - AACR
AACR shared on X/Twitter: "Engineering T Cells to Eradicate Tumors: Identifying and Overcoming the Obstacles —…
Apr 11, 2024, 12:45 | Insight
Important IMvoke010 trial could shape future research in immunotherapy in locally advanced head and neck cancer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared on X/Twitter: "Important IMvoke010 trial could shape future research in immunotherapy…
Apr 11, 2024, 12:38 | Blog
Key drugs at AACR 2024 by LARVOL
LARVOL shared on X/Twitter: "Exploring the key drugs at AACR 2024? Dive into the abstracts, including…
Apr 11, 2024, 12:21 | Blog
Paolo Tarantino: Easier to get a ticket for a Taylor Swift concert than to find a seat at the AACR24 Next Generation ADC session!
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Apr 11, 2024, 12:10 | Blog
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery
Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…
Apr 11, 2024, 11:56 | Blog
Guru P. Sonpavde: AACR⁩ - Many promising options for Phase I clinical trials
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter: "AACR24 ⁦AACR⁩…
Apr 11, 2024, 11:47 | Career
Congratulations to Mariana Xavier Byndloss on receiving the Excellence in Science Early Career Investigator Award - HHMI NEWS
HHMI NEWS shared on X: “Congratulations to Mariana Xavier Byndloss, Freeman Hrabowski Scholar and Vanderbilt…
All: 16009 Posts: 9301 - 9400